Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to 0.28%.

  • CorMedix's Return on Capital Employed rose 12100.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 12100.0%. This contributed to the annual value of 0.52% for FY2022, which is 300.0% up from last year.
  • Latest data reveals that CorMedix reported Return on Capital Employed of 0.28% as of Q3 2025, which was up 12100.0% from 0.29% recorded in Q2 2025.
  • CorMedix's 5-year Return on Capital Employed high stood at 0.29% for Q2 2025, and its period low was 1.05% during Q2 2024.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.48% (2022), whereas its average is 0.44%.
  • In the last 5 years, CorMedix's Return on Capital Employed tumbled by -3000bps in 2024 and then surged by 13400bps in 2025.
  • CorMedix's Return on Capital Employed (Quarter) stood at 0.44% in 2021, then decreased by -25bps to 0.55% in 2022, then dropped by -14bps to 0.63% in 2023, then surged by 45bps to 0.35% in 2024, then surged by 181bps to 0.28% in 2025.
  • Its last three reported values are 0.28% in Q3 2025, 0.29% for Q2 2025, and 0.14% during Q1 2025.